Continuous Postoperative Blood Glucose Monitoring and Control by an Artificial Pancreas in Patients Undergoing Pancreatic Resection: A Prospective Randomized Clinical Trial
N/A
N/A
Both
Pancreatic Neoplasm
Trial Information
Continuous Postoperative Blood Glucose Monitoring and Control by an Artificial Pancreas in Patients Undergoing Pancreatic Resection: A Prospective Randomized Clinical Trial
This study recruited 32 patients undergoing elective pancreatic resection for pancreatic
disease.
Inclusion Criteria:
- This study recruited 32 patients undergoing elective pancreatic resection for
pancreatic disease.
Exclusion Criteria:
- weight loss greater than 10% during the previous 6 months
- signs of distant metastasis
- respiratory, renal,or heart disease
- Patients provided written informed consent prior to enrollment
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Outcome Measure:
the incidence of severe hypoglycemia (< 40 mg/dl) during the intensive care period following pancreatic resection in patients monitored using the artificial pancreas
Outcome Time Frame:
the first postoperative 18 hours in the surgical intensive care unit
Safety Issue:
Yes
Principal Investigator
Takehiro Okabayashi, MD
Investigator Role:
Study Director
Investigator Affiliation:
Kochi Medical School, Kochi University
Authority:
Japan: Ministry of Education, Culture, Sports, Science and Technology
Study ID:
TGC-AP-01
NCT ID:
NCT00657995
Start Date:
April 2007
Completion Date:
December 2007
Related Keywords:
- Pancreatic Neoplasm
- pancreatogenic
- diabetes
- artificial
- pancreas
- Neoplasms
- Pancreatic Neoplasms
Name | Location |
|---|
